Nevro Corp (NVRO) - Product Pipeline Analysis, 2024 Update

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $750	49 Pages	GlobalData	May, 2024	GBDT18861596

Best Price Guarantee
Price	from $750
Length	49 Pages
Publisher	GlobalData
Published Date	May, 2024
SKU	GBDT18861596

Nevro Corp (NVRO) - Product Pipeline Analysis, 2024 Update

Summary

Nevro Corp (Nevro) is a medical device company, which is engaged in developing novel products that advance the quality of life for people suffering from chronic pain in trunks and limbs. The company has developed Nevro Senza spinal cord stimulation (SCS) system, a non-pharmacological neuromodulation platform for the treatment of chronic pain. The Nevro Senza SCS system is commercially available in Europe, the US, and Australia. The company offers products under Senza, Senza II, Senza Omnia and the Nevro logo brands. Nevro is developing HF10 therapy for treatment related to painful diabetic neuropathy and non-surgical refractory back pain. Nevro is headquartered in Redwood City, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Nevro Corp
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Nevro Corp Company Overview: Nevro Corp Company Snapshot; Nevro Corp Pipeline Products and Ongoing Clinical Trials Overview; Nevro Corp – Pipeline Analysis Overview; Business Description; Nevro Corp - Key Facts; Nevro Corp - Major Products and Services; Nevro Corp Pipeline Products by Development Stage; Nevro Corp Ongoing Clinical Trials by Trial Status; Nevro Corp Pipeline Products Overview; Senza HF10 Therapy System - Back Pain; Senza HF10 Therapy System - Back Pain Product Overview; Senza HF10 Therapy System - Chronic Abdominal Pain; Senza HF10 Therapy System - Chronic Abdominal Pain Product Overview; Senza HF10 Therapy System - Chronic Migraine; Senza HF10 Therapy System - Chronic Migraine Product Overview; Senza HF10 Therapy System - Chronic Neck Pain; Senza HF10 Therapy System - Chronic Neck Pain Product Overview; Senza HF10 Therapy System - CPSP; Senza HF10 Therapy System - CPSP Product Overview; Senza HF10 Therapy System - Leg Pain; Senza HF10 Therapy System - Leg Pain Product Overview; Senza HF10 Therapy System - Opioid Reduction; Senza HF10 Therapy System - Opioid Reduction Product Overview; Senza HF10 Therapy System - Painful Diabetic Neuropathy; Senza HF10 Therapy System - Painful Diabetic Neuropathy Product Overview; Senza HF10 Therapy System - Painful Diabetic Neuropathy Clinical Trial; Senza HF10 Therapy System - Pelvic Pain; Senza HF10 Therapy System - Pelvic Pain Product Overview; Senza HF10 Therapy System - Pelvic Pain Clinical Trial; Senza HF10 Therapy System - Peripheral Polyneuropathy; Senza HF10 Therapy System - Peripheral Polyneuropathy Product Overview; Senza HF10 Therapy System - Post-Surgical Pain; Senza HF10 Therapy System - Post-Surgical Pain Product Overview; Senza HF10 Therapy System - Rescue Therapy; Senza HF10 Therapy System - Rescue Therapy Product Overview; Senza HF10 Therapy System - Thoracic Pain; Senza HF10 Therapy System - Thoracic Pain Product Overview; Senza HF10 Therapy System - Upper Extremity Pain; Senza HF10 Therapy System - Upper Extremity Pain Product Overview; Senza HF10 Therapy System - Upper Limb Pain; Senza HF10 Therapy System - Upper Limb Pain Product Overview; Senza HFX iQ Spinal Cord Stimulation System; Senza HFX iQ Spinal Cord Stimulation System Product Overview; Nevro Corp - Key Competitors; Nevro Corp - Key Employees; Nevro Corp - Key Employee Biographies; Nevro Corp - Locations And Subsidiaries; Head Office; Other Locations & Subsidiaries; Recent Developments; Nevro Corp, Recent Developments; Feb 28, 2024: Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral Screw; Feb 01, 2024: Nevro Announces Consensus Statement Supporting High-Frequency (10 kHz) Spinal Cord Stimulation Therapy for Refractory Painful Diabetic Neuropathy; Jan 29, 2024: Nevro to Report Fourth-Quarter and Full-Year 2023 Financial Results and Host Conference Call on February 21, 2024; Jan 18, 2024: Nevro Announces Positive Coverage Update from Carelon Healthcare for the Treatment of Painful Diabetic Neuropathy; Jan 17, 2024: Nevro to Highlight 25 Scientific Abstracts at 2024 North American Neuromodulation Society (NANS) Annual Meeting; Jan 10, 2024: Nevro Laying Off 63 People To Strengthen Financial Position; Nov 20, 2023: Nevro Delivers Long-Term Relief with High-Frequency Spinal Cord Stimulation: 24-Month Data Demonstrates Profound Improvements for Non-Surgical Refractory Back Pain; Oct 04, 2023: Nevro to Report Third Quarter 2023 Financial Results; Sep 18, 2023: New Data Demonstrate the Health Economic Benefits of Nevro's High-Frequency Spinal Cord Stimulation Therapy; Aug 16, 2023: New 24-Month Data Shows Nevro's SCS Therapy Provides Highly Effective, Long-Term Relief from Painful Diabetic Neuropathy
Appendix: Methodology; About GlobalData; Contact Us; Disclaimer
List of Tables: Table 1: Nevro Corp Pipeline Products and Ongoing Clinical Trials Overview; Table 2: Nevro Corp Pipeline Products by Equipment Type; Table 3: Nevro Corp Pipeline Products by Indication; Table 4: Nevro Corp, Key Facts; Table 5: Nevro Corp, Major Products and Services; Table 6: Nevro Corp Number of Pipeline Products by Development Stage; Table 7: Nevro Corp Pipeline Products Summary by Development Stage; Table 8: Nevro Corp Ongoing Clinical Trials by Trial Status; Table 9: Nevro Corp Ongoing Clinical Trials Summary; Table 10: Senza HF10 Therapy System - Back Pain - Product Status; Table 11: Senza HF10 Therapy System - Back Pain - Product Description; Table 12: Senza HF10 Therapy System - Chronic Abdominal Pain - Product Status; Table 13: Senza HF10 Therapy System - Chronic Abdominal Pain - Product Description; Table 14: Senza HF10 Therapy System - Chronic Migraine - Product Status; Table 15: Senza HF10 Therapy System - Chronic Migraine - Product Description; Table 16: Senza HF10 Therapy System - Chronic Neck Pain - Product Status; Table 17: Senza HF10 Therapy System - Chronic Neck Pain - Product Description; Table 18: Senza HF10 Therapy System - CPSP - Product Status; Table 19: Senza HF10 Therapy System - CPSP - Product Description; Table 20: Senza HF10 Therapy System - Leg Pain - Product Status; Table 21: Senza HF10 Therapy System - Leg Pain - Product Description; Table 22: Senza HF10 Therapy System - Opioid Reduction - Product Status; Table 23: Senza HF10 Therapy System - Opioid Reduction - Product Description; Table 24: Senza HF10 Therapy System - Painful Diabetic Neuropathy - Product Status; Table 25: Senza HF10 Therapy System - Painful Diabetic Neuropathy - Product Description; Table 26: Senza HF10 Therapy System - Painful Diabetic Neuropathy - A Post-market, Multicenter, Prospective, Global Clinical Study to Evaluate the Real-world Experience of Spinal Cord Stimulation That Includes 10 kHz in the Management of Chronic Intractable Pain Associated with Diabetic Neuropathy; Table 27: Senza HF10 Therapy System - Painful Diabetic Neuropathy - PDN-SENSORY: A Multi-Center Randomized Controlled Trial to Evaluate Pain and Neurological Function with 10 kHz SCS in Treatment of Painful Diabetic Neuropathy; Table 28: Senza HF10 Therapy System - Pelvic Pain - Product Status; Table 29: Senza HF10 Therapy System - Pelvic Pain - Product Description; Table 30: Senza HF10 Therapy System - Pelvic Pain - A Prospective Clinical Study to Assess the Spinal Cord Stimulation System in the Treatment of Chronic Pelvic Pain; Table 31: Senza HF10 Therapy System - Peripheral Polyneuropathy - Product Status; Table 32: Senza HF10 Therapy System - Peripheral Polyneuropathy - Product Description; Table 33: Senza HF10 Therapy System - Post-Surgical Pain - Product Status; Table 34: Senza HF10 Therapy System - Post-Surgical Pain - Product Description; Table 35: Senza HF10 Therapy System - Rescue Therapy - Product Status; Table 36: Senza HF10 Therapy System - Rescue Therapy - Product Description; Table 37: Senza HF10 Therapy System - Thoracic Pain - Product Status; Table 38: Senza HF10 Therapy System - Thoracic Pain - Product Description; Table 39: Senza HF10 Therapy System - Upper Extremity Pain - Product Status; Table 40: Senza HF10 Therapy System - Upper Extremity Pain - Product Description; Table 41: Senza HF10 Therapy System - Upper Limb Pain - Product Status; Table 42: Senza HF10 Therapy System - Upper Limb Pain - Product Description; Table 43: Senza HFX iQ Spinal Cord Stimulation System - Product Status; Table 44: Senza HFX iQ Spinal Cord Stimulation System - Product Description; Table 45: Nevro Corp, Key Employees; Table 46: Nevro Corp, Key Employee Biographies; Table 47: Nevro Corp, Subsidiaries; Table 48: Glossary
List of Figures: Figure 1: Nevro Corp Pipeline Products by Equipment Type; Figure 2: Nevro Corp Pipeline Products by Development Stage; Figure 3: Nevro Corp Ongoing Clinical Trials by Trial Status